Logo image of BCO.DE

BOEING CO/THE (BCO.DE) Stock Fundamental Analysis

FRA:BCO - Deutsche Boerse Ag - US0970231058 - Common Stock - Currency: EUR

139.6  -10.06 (-6.72%)

Fundamental Rating

1

BCO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 38 industry peers in the Aerospace & Defense industry. BCO has a bad profitability rating. Also its financial health evaluation is rather negative. BCO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BCO has reported negative net income.
In the past year BCO has reported a negative cash flow from operations.
BCO had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BCO reported negative operating cash flow in multiple years.
BCO.DE Yearly Net Income VS EBIT VS OCF VS FCFBCO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

The Return On Assets of BCO (-7.59%) is worse than 84.21% of its industry peers.
Industry RankSector Rank
ROA -7.59%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BCO.DE Yearly ROA, ROE, ROICBCO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BCO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCO.DE Yearly Profit, Operating, Gross MarginsBCO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

BCO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BCO has more shares outstanding
The number of shares outstanding for BCO has been increased compared to 5 years ago.
Compared to 1 year ago, BCO has an improved debt to assets ratio.
BCO.DE Yearly Shares OutstandingBCO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BCO.DE Yearly Total Debt VS Total AssetsBCO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

BCO has an Altman-Z score of 1.00. This is a bad value and indicates that BCO is not financially healthy and even has some risk of bankruptcy.
BCO has a Altman-Z score of 1.00. This is in the lower half of the industry: BCO underperforms 76.32% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1
ROIC/WACCN/A
WACC8.52%
BCO.DE Yearly LT Debt VS Equity VS FCFBCO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

A Current Ratio of 1.32 indicates that BCO should not have too much problems paying its short term obligations.
BCO has a better Current ratio (1.32) than 76.32% of its industry peers.
A Quick Ratio of 0.42 indicates that BCO may have some problems paying its short term obligations.
The Quick ratio of BCO (0.42) is worse than 86.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.42
BCO.DE Yearly Current Assets VS Current LiabilitesBCO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

3

3. Growth

3.1 Past

BCO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -250.00%.
The Revenue for BCO has decreased by -14.50% in the past year. This is quite bad
The Revenue has been decreasing by -4.74% on average over the past years.
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%

3.2 Future

BCO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.11% yearly.
BCO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.55% yearly.
EPS Next Y92.35%
EPS Next 2Y48.3%
EPS Next 3Y33.32%
EPS Next 5Y20.11%
Revenue Next Year24.84%
Revenue Next 2Y20.42%
Revenue Next 3Y17.17%
Revenue Next 5Y15.55%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BCO.DE Yearly Revenue VS EstimatesBCO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
BCO.DE Yearly EPS VS EstimatesBCO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BCO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BCO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BCO.DE Price Earnings VS Forward Price EarningsBCO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCO.DE Per share dataBCO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as BCO's earnings are expected to grow with 33.32% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.3%
EPS Next 3Y33.32%

More info and screens

0

5. Dividend

5.1 Amount

BCO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOEING CO/THE

FRA:BCO (3/7/2025, 7:00:00 PM)

139.6

-10.06 (-6.72%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)04-22 2025-04-22/bmo
Inst Owners75.41%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap104.71B
Analysts77.78
Price Target196.13 (40.49%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.86
Dividend Growth(5Y)-11.02%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.7%
Min EPS beat(2)-91.07%
Max EPS beat(2)3.66%
EPS beat(4)2
Avg EPS beat(4)-23.11%
Min EPS beat(4)-91.07%
Max EPS beat(4)37.77%
EPS beat(8)4
Avg EPS beat(8)-7.22%
EPS beat(12)4
Avg EPS beat(12)-872.64%
EPS beat(16)5
Avg EPS beat(16)-763.86%
Revenue beat(2)0
Avg Revenue beat(2)-5.74%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-2.77%
Revenue beat(4)0
Avg Revenue beat(4)-4.33%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)-0.87%
Revenue beat(8)2
Avg Revenue beat(8)-1.93%
Revenue beat(12)2
Avg Revenue beat(12)-4.68%
Revenue beat(16)2
Avg Revenue beat(16)-5.02%
PT rev (1m)8.15%
PT rev (3m)10.27%
EPS NQ rev (1m)1.88%
EPS NQ rev (3m)-168.28%
EPS NY rev (1m)-30893.5%
EPS NY rev (3m)-428.99%
Revenue NQ rev (1m)1.88%
Revenue NQ rev (3m)-0.33%
Revenue NY rev (1m)0.44%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.71
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-18.76
EYN/A
EPS(NY)-1.43
Fwd EYN/A
FCF(TTM)-17.68
FCFYN/A
OCF(TTM)-14.83
OCFYN/A
SpS81.68
BVpS-4.8
TBVpS-17.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.59%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 126.25%
Cap/Sales 3.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.42
Altman-Z 1
F-Score2
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-250%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1155.32%
EPS Next Y92.35%
EPS Next 2Y48.3%
EPS Next 3Y33.32%
EPS Next 5Y20.11%
Revenue 1Y (TTM)-14.5%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%-30.77%
Revenue Next Year24.84%
Revenue Next 2Y20.42%
Revenue Next 3Y17.17%
Revenue Next 5Y15.55%
EBIT growth 1Y-1218.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year149.06%
EBIT Next 3Y50.8%
EBIT Next 5Y32.37%
FCF growth 1Y-424.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-302.68%
OCF growth 3YN/A
OCF growth 5YN/A